Description

Lenvanix (Lenvatinib) 4mg Capsules – 30’s Pack

Overview:
Lenvanix contains Lenvatinib 4mg, a targeted cancer therapy belonging to the class of multi-kinase inhibitors. It works by blocking specific proteins (VEGFR1, VEGFR2, VEGFR3, FGFR, PDGFRα, KIT, RET) that play a crucial role in tumor growth and angiogenesis (the development of new blood vessels that feed tumors). Lenvanix is widely prescribed for thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC).

---

Key Details

• Brand Name: Lenvanix

• Generic Name: Lenvatinib

• Strength: 4 mg capsules

• Pack Size: 30 capsules per bottle

• Class: Multi-kinase inhibitor / Targeted cancer therapy

• Manufacturer Origin: Imported

• Prescription: Required, oncology specialist supervision only

---

Approved Uses / Indications

Lenvanix (Lenvatinib) 4mg is used in the treatment of:

• Differentiated Thyroid Cancer (DTC) – in patients who are resistant to radioactive iodine therapy.

• Renal Cell Carcinoma (RCC) – in combination with Everolimus 5mg daily.

• Hepatocellular Carcinoma (HCC) – in patients who are not suitable for surgical or local treatment.

---

Recommended Dosage & Administration

• Differentiated Thyroid Cancer (DTC): 24 mg orally once daily.

• Renal Cell Carcinoma (RCC): 18 mg orally once daily + Everolimus 5 mg once daily.

• Hepatocellular Carcinoma (HCC):

  • ≥60 kg body weight: 12 mg orally once daily.

  • <60 kg body weight: 8 mg orally once daily.

💊 Note: Dosage adjustments may be required for patients with liver or kidney impairment. Always follow your oncologist’s instructions.

---

How Lenvanix Works (Mechanism of Action)

• VEGFR1, VEGFR2, VEGFR3 Inhibition: Blocks vascular endothelial growth factor receptors to cut off blood supply to tumors.

• FGFR, PDGFRα, KIT & RET Blockade: Inhibits additional growth factor receptors linked to cancer progression.

• Multi-Pathway Suppression: Stops multiple tumor signaling pathways, slowing cancer growth and spread.

---

Common Side Effects

Like other targeted cancer therapies, Lenvanix may cause side effects:

• Very Common: Hypertension, fatigue, diarrhea, decreased appetite, nausea.

• Dermatological: Palmar-plantar erythrodysesthesia syndrome (hand-foot skin reaction).

• Serious Risks: Liver/kidney dysfunction, proteinuria, cardiac complications.

⚠️ Patients require regular blood pressure monitoring and liver/kidney function tests during treatment.

---

Storage Guidelines

• Store below 30°C (86°F) in a cool, dry place.

• Keep tightly closed in original packaging.

• Keep out of reach of children.

---

Why Choose Lenvanix (Lenvatinib)?

• Clinically proven to extend progression-free survival in thyroid, renal, and liver cancers.

• Targeted therapy – specifically blocks cancer growth pathways.

• Available in convenient oral capsule form.

• Recognized worldwide under the brand name Lenvima (developed by Eisai Co., Ltd).

---

Safety Advice

• Must be taken under strict medical supervision.

• Do not adjust or skip doses without consulting your oncologist.

• Inform your doctor about other medications you are taking to avoid interactions.

• Not recommended during pregnancy or breastfeeding.